+Compare
PFE
Stock ticker:
NYSE
AS OF
Sep 23 closing price
Price
$44.08
Change
-$0.49 (-1.10%)
Capitalization
247.39B

PFE Price Prediction, Pfizer AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
GET INTRADAY SIGNALS
PFE Trading results, last 6 months
AI Robots NameP/L
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Sep 23, 2022

PFE's RSI Oscillator ascends from oversold territory

The RSI Oscillator for PFE moved out of oversold territory on September 22, 2022. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 25 of the 33 cases the stock moved higher. This puts the odds of a move higher at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PFE advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

PFE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on PFE as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PFE turned negative on September 20, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PFE entered a downward trend on September 23, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.837) is normal, around the industry mean (5.173). P/E Ratio (8.576) is within average values for comparable stocks, (90.169). Projected Growth (PEG Ratio) (1.110) is also within normal values, averaging (3.089). Dividend Yield (0.036) settles around the average of (0.029) among similar stocks. P/S Ratio (2.499) is also within normal values, averaging (3.618).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PFE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

PFE is expected to report earnings to fall 26.47% to $1.50 per share on November 01

Pfizer PFE Stock Earnings Reports
Q3'22
Est.
$1.50
Q2'22
Beat
by $0.32
Q1'22
Beat
by $0.13
Q4'21
Beat
by $0.21
Q3'21
Beat
by $0.26
The last earnings report on July 28 showed earnings per share of $2.04, beating the estimate of $1.72. With 18.59M shares outstanding, the current market capitalization sits at 247.39B.
AI
A.I.Advisor
published Dividends

PFE paid dividends on September 06, 2022

Pfizer PFE Stock Dividends
А dividend of $0.40 per share was paid with a record date of September 06, 2022, and an ex-dividend date of July 28, 2022. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Pfizer (NYSE:PFE), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 71.41B. The market cap for tickers in the group ranges from 226K to 438.34B. JNJ holds the highest valuation in this group at 438.34B. The lowest valued company is NEWG at 226K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -12%. RHHVF experienced the highest price growth at 3%, while GIFLF experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -32%. For the same stocks of the Industry, the average monthly volume growth was 51% and the average quarterly volume growth was 15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 19
P/E Growth Rating: 41
Price Growth Rating: 65
SMR Rating: 41
Profit Risk Rating: 69
Seasonality Score: -18 (-100 ... +100)
AI
View a ticker or compare two or three
PFE
Buy/Sell Ratings
 
 
Technical Analysis# Of IndicatorsAvg. Odds
   
   
 
AI
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and injectable biologic medicines

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
235 East 42nd Street
Phone
+1 212 733-2323
Employees
79000
Web
https://www.pfizer.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNS2.200.04
+1.85%
Genius Group Limited
CWST78.39-0.24
-0.31%
Casella Waste Systems
EQIX593.13-16.13
-2.65%
Equinix
ATRA3.31-0.10
-2.93%
Atara Biotherapeutics
RADI11.54-0.57
-4.71%
Radius Global Infrastructure

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with LLY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
-1.10%
LLY - PFE
47%
Loosely correlated
+0.19%
ABBV - PFE
45%
Loosely correlated
+0.03%
BMY - PFE
44%
Loosely correlated
-0.81%
JNJ - PFE
42%
Loosely correlated
+0.32%
NVS - PFE
40%
Loosely correlated
-1.46%
More